Moderna, Inc. (MRNA) Gross margin 2018–2025
Moderna, Inc. (MRNA) gross margin by fiscal year — reported gross profit divided by reported revenue.
55.3%FY2025 · since FY2018: 100.0% → 55.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 55.3% | +0.6 pp |
| FY2024 | 54.8% | +23.3 pp |
| FY2023 | 31.5% | -40.4 pp |
| FY2022 | 71.9% | -13.9 pp |
| FY2021 | 85.8% | -13.2 pp |
| FY2020 | 99.0% | -1.0 pp |
| FY2019 | 100.0% | +0.0 pp |
| FY2018 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MRNA financial trends
MRNA RevenueMRNA Net incomeMRNA Net marginMRNA Gross profitMRNA Operating incomeMRNA Operating marginMRNA Operating cash flowMRNA Free cash flowMRNA Capital expendituresMRNA Return on equityMRNA Stock buybacksMRNA Dividends paidMRNA Total assetsMRNA Total liabilitiesMRNA Shareholders’ equityMRNA overview →